The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).
about
Staphylococcal Superantigens Spark Host-Mediated Danger SignalsMolecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic reviewMRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine EvaluationFlipping the switch: tools for detecting small molecule inhibitors of staphylococcal virulence.High-density livestock production and molecularly characterized MRSA infections in PennsylvaniaNatural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formationPhotothermal killing of Staphylococcus aureus using antibody-targeted gold nanoparticles.Prevalence, Virulence Genes, Antimicrobial Susceptibility, and Genetic Diversity of Staphylococcus aureus from Retail Aquatic Products in China.Humanized Mouse Models of Staphylococcus aureus Infection.Community-associated methicillin-resistant Staphylococcus aureus case studies.Emergence of new CMRSA7/USA400 methicillin-resistant Staphylococcus aureus spa types in Alberta, Canada, from 2005 to 2012Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.The psmα locus regulates production of Staphylococcus aureus alpha-toxin during infectionHumanized staphylococcal enterotoxin B (SEB)-specific monoclonal antibodies protect from SEB intoxication and Staphylococcus aureus infections alone or as adjunctive therapy with vancomycinTargeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.Contamination of environmental surfaces with Staphylococcus aureus in households with children infected with methicillin-resistant S aureus.Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).Identifying methicillin-resistant Staphylococcus aureus (MRSA) lung infections in mice via breath analysis using secondary electrospray ionization-mass spectrometry (SESI-MS)Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance.An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA)Oritavancin for acute bacterial skin and skin structure infections.Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis.Frequency of methicillin-resistant Staphylococcus aureus nasal carriage in healthy children.Global antibody response to Staphylococcus aureus live-cell vaccinationPotentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies.Global economic burden of Chagas disease: a computational simulation modelCost-effectiveness and efficacy of spa, SCCmec, and PVL genotyping of methicillin-resistant Staphylococcus aureus as compared to pulsed-field gel Electrophoresis.Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.A Mouse Model of Multi-Drug Resistant Staphylococcus aureus-induced Ocular DiseaseEconomic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.The Penicillin for the Emergency Department Outpatient treatment of CELLulitis (PEDOCELL) trial: update to the study protocol and detailed statistical analysis plan (SAP).CodY, a master integrator of metabolism and virulence in Gram-positive bacteria.Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: a systematic review, network meta-analysis and cost analysis.Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.Prevalence of Nasal colonization with Staphylococcus aureus in 4 cities in PeruDevelopment of persistent gastrointestinal S. aureus carriage in mice.Coagulase-Negative Staphylococcal Strain Prevents Staphylococcus aureus Colonization and Skin Infection by Blocking Quorum Sensing.Antimicrobial resistance and antimicrobial use animal monitoring policies in Europe: Where are we ?
P2860
Q26766421-E4C6C866-009E-4C1D-8EF2-B7750A65AAC1Q27006781-753AD035-7EDC-4282-A312-CF345D2B7458Q27348782-022C7071-6446-4CB1-8293-729BF200CEF1Q27692092-5633D2DF-D495-4ADF-86B1-7F4C8119D2DEQ28385457-D5C0CF74-AA04-4041-9DA6-7FF704F5F4FEQ30017477-E8B7AE32-A303-428E-83CB-30F26883FF8AQ30415264-78C5CF41-A141-4F54-9FB4-337FBCD39AB9Q33583115-22BD6148-818B-4AF6-B79E-E896B14A8542Q33634034-420BCDB4-F781-4C6B-B736-878EDD7A4FC1Q33792021-293B9051-6949-41FC-ADC3-68CA8CCD2B55Q33900198-B3EC4483-639A-4C12-AE4C-0D48B845B48CQ34047858-9003B8F7-4FD7-4FF7-B983-D762157D622DQ34058980-AC3E1624-0D1B-41C0-A960-72E2AA824A97Q34315661-F5064DC8-ACB9-4019-A11B-72D1F127D96FQ34396053-60863ED5-2176-4589-96F3-0D69DBC69DFAQ34437424-253CC670-E3C1-49AD-B629-DE6FD3A71EB2Q35577377-7E34D2FA-1F81-4D93-BAB5-916C104DD388Q35647084-B44C155D-7F31-4F5E-BAA0-E0F26541421BQ35751036-EE532F59-B7B7-4E4A-BD47-2BA4BD5AAF95Q35973180-31933C9B-1226-4EC7-9704-E9F843CE0C8FQ36086423-0BCEC070-F31D-42CF-A619-963106DA5717Q36198455-BA37CE82-1AC5-41C2-B5F5-E09F9965D8C8Q36327319-C01613EA-7968-4B34-932C-299B8B56B4FBQ36824281-FB0856C9-8397-41B2-AACE-1936D9F7A513Q36986737-DA46E5E6-7886-4D78-956E-36193B9AA13EQ37147573-F57E059D-639C-40DF-8299-DDE5F8EA49CEQ37309206-181BA707-0B0F-437B-8DEA-3F46492EBC3EQ37332203-4566590A-2463-4093-924F-2EA0DE132EFFQ37441216-D3AFE305-2D85-43DC-8F92-80582F4FC476Q38275128-2DE03947-19BD-4905-AC28-D9FB736FB23AQ38286351-22C59F54-76A6-4679-B751-03EFF14E7CDDQ38610453-46C29C38-4AAC-459C-85A5-C8EC423878E5Q38981751-F94B056C-E56F-4453-B982-C1EB3406BFF9Q40052636-4BF755CA-DE7C-4E56-BF0A-8DD9BF939AF9Q40187951-2E4DCB9D-DC0B-4D82-ADFD-70E72EEF4C28Q40449041-B557FB8D-D38A-4C1C-8909-67410B9C3925Q41149963-18F85A35-57F0-4934-8204-57AD72A305F5Q42367780-9F2B7FCB-ECDF-4E13-8DB6-EE719222F66BQ46249180-EC251945-1890-4932-9477-B3C608361C5DQ46362222-6FA63CFC-8BB9-47EC-BF9A-6CB5559FE0E9
P2860
The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
The economic burden of communi ...... aphylococcus aureus (CA-MRSA).
@ast
The economic burden of communi ...... aphylococcus aureus (CA-MRSA).
@en
type
label
The economic burden of communi ...... aphylococcus aureus (CA-MRSA).
@ast
The economic burden of communi ...... aphylococcus aureus (CA-MRSA).
@en
prefLabel
The economic burden of communi ...... aphylococcus aureus (CA-MRSA).
@ast
The economic burden of communi ...... aphylococcus aureus (CA-MRSA).
@en
P2093
P2860
P1476
The economic burden of communi ...... taphylococcus aureus (CA-MRSA)
@en
P2093
D S Lauderdale
L G Miller
M A Potter
S M Bartsch
S M Zimmer
P2860
P304
P356
10.1111/J.1469-0691.2012.03914.X
P577
2012-06-19T00:00:00Z